IP Library Granted Patent US 9,205,240
Granted Patent B2
US 9,205,240 · App. 13/139,781 · Granted Dec 8, 2015

Powder delivery device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,205,240
App. No.
13/139,781
Granted
Dec 8, 2015
Kind
B2
Abstract

A device for the topical dispensing of a powder, typically a powder medicament, comprises, or is adapted to be coupled to, a powder receptacle and a gasflow generator. The gasflow generator is adapted, in use, to cause gas to flow through the device, which further comprises an agitator by which the powder and/or the powder receptacle can be mechanically agitated. Actuation of the gasflow generator, which causes gas to flow through the device and to entrain powder from the powder receptacle, thereby to dispense powder from the device, is accompanied by actuation of the agitator, causing the powder receptacle to be mechanically agitated, thereby facilitating the release of powder from the powder receptacle.

Claims (34)

1. A device for the topical dispensing of a powder comprising:

a powder receptacle storing the powder;

a gasflow generator adapted, in use, to cause gas to flow through the device, the gasflow generator being external to the device and comprising a connector which is adapted to be coupled to the gasflow generator;

an actuator;

a trumpet valve; and

an agitator configured to mechanically vibrate the powder receptacle to release powder from the powder receptacle,

the gasflow generator, the actuator, the valve and the agitator being operably linked such that actuation of the actuator causes the valve to open, permitting gas to flow through the device, actuating the agitator to cause the receptacle to be mechanically vibrated to release the powder and to entrain the powder that has been released from the powder receptacle in the gas flow, thereby to dispense powder from the device, wherein the agitator is driven by the gasflow, such that the agitator operates for as long as the valve is open and the gas flows and is disengaged when the flow of gas is halted, and wherein the agitator includes a moveable agitator element that is positioned within a path of the gasflow,

wherein the powder is a haemostatic composition and the device is configured to dispense powder through a gas flow outlet to internal tissues exposed during surgical procedures or after traumatic injury, the powder being dispensed from the powder receptacle until the actuator is selectively unactuated by a user.

2. A device as claimed in claim 1 , wherein the moveable agitator element is mounted such that its movement generates mechanical disturbances or vibrations within the device without contacting the powder, leading to physical agitation of the powder contained within the powder receptacle.

3. A device as claimed in claim 1 , wherein the path of the gas flow includes a loop within which the movable agitator element is caused to rotate.

4. A device as claimed in claim 3 , wherein the loop is a circular track and the movable agitator element is a ball that is driven around the track by the gas flow.

5. A device as claimed in claim 1 , wherein the powder receptacle is a vial integrally engaged with the device, such that the device is supplied with a quantity of powder contained within the vial.

6. A device as claimed in claim 1 , wherein the powder receptacle is a separate component that is coupled to the device prior to use.

7. A device as claimed in claim 6 , wherein the device and the receptacle are formed with cooperating formations that enable them to be coupled together.

8. A device as claimed in claim 7 , wherein the device is formed with an upstand or spigot that is received within or about a neck of the powder receptacle.

9. A device as claimed in claim 6 , wherein the powder receptacle is supplied in the form of a sealed vial that contains a bulk quantity of powder.

10. A device as claimed in claim 1 , wherein the external gasflow generator is a source of compressed gas.

11. A device as claimed in claim 1 , wherein the gasflow generator comprises a compressible bulb or bellows that can be manually compressed by the user.

12. A device as claimed in claim 1 , wherein the gasflow generator is a canister of a compressed gas or a liquefied propellant.

13. A device as claimed in claim 1 , which includes an outer housing that facilitates operation of the device.

14. A device as claimed in claim 13 , wherein the outer housing is configured such that the device can be readily held and operated by the user in one hand.

15. A method of delivering the haemostatic composition to the internal tissue exposed during surgical procedures or after traumatic injury, which method comprises providing a device as claimed in claim 1 , which device is charged with a quantity of the haemostatic composition in dry powder form, and dispensing said haemostatic composition from said device onto said exposed internal tissue.

16. A method as claimed in claim 15 , wherein said haemostatic composition comprises fibrinogen and thrombin.

17. A device as claimed in claim 1 , wherein the gas flows along a first gas path configured to receive gas from a gas supply at one end of the first gas path and to exhaust the gas supply to atmosphere at another end of the first gas path, the gasflow in the first gas path driving the agitator, and wherein a portion of the gas in the first gas path is directed into a second gas path configured such that the gas in the second gas path entrains a quantity of powder from the powder receptacle.

18. A device for the topical dispensing of a powder comprising:

a body;

a powder receptacle storing the powder in fluid communication with the body;

an agitator configured to vibrate the powder receptacle in response to a gas flow;

a gas flow generator configured to generate the gas flow through:

a first gas path entering the body configured to receive gas from a gas supply at one end of the first gas path to mechanically agitate the agitator and to exhaust the gas supply to atmosphere at another end of the first gas path; and

a second gas path configured to direct a portion of the gas in the first gas path proximate the powder receptacle to entrain a quantity of powder released into the second gas path due to mechanical agitation by the agitator, the second gas path further configured to deliver the powder to a desired location;

a valve; and

an actuator, which is operably linked to the gasflow generator via the valve, and to the agitator, wherein the powder is dispensed to the desired location until the actuator is selectively unactuated by a user.

19. A device as claimed in claim 18 , wherein the gas flow generator is an external gas flow generator, the device further comprising a connector which is adapted to be coupled to the external gas flow generator.

Assignments (16)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 73375 FRAME 395. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 72331 FRAME 1. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: SPECGX LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 043596, FRAME 0259 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0324 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
NUNC PRO TUNC ASSIGNMENT Recorded Oct 6, 2017
From: PROFIBRIX B.V.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 043806/0028 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Aug 18, 2017
From: MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 043596/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2011
From: GREENHALGH, PAUL; GRIMBERGEN, JOSEPH MARIA; HARVEY, OLIVER
To: PROFIBRIX B.V.
Reel/Frame 026448/0138 →